CURE’s breast cancer page is an extensive resource of cancer information featuring the latest breast cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on breast cancer.
May 2nd 2025
New results from a breast cancer-related lymphedema study show the importance of measuring fluid and body composition before treatment begins.
How Accurate Are Tumor Markers?
August 2nd 2017There are many questions associated with breast cancer testing and their accuracy. Do tumor markers give accurate understanding of what's happening in an person's body? Why do some doctors use the test and some do not? These are just a couple of the questions we need answered.
Sexual Intimacy After Breast Cancer, a Taboo Subject
July 24th 2017Sexual intimacy is a subject that is difficult for many breast cancer survivors to discuss. The challenges of sexual intimacy are often created as a direct result of cancer treatments or can occur from the after effects which result in emotional scarring.
When Is It Time To Find a New Oncologist?
July 18th 2017The doctor-patient relationship is a delicate one. It's one that needs to be comfortable between both parties. When and how do breast cancer patients know when it's time to make a change? This is an important decision that should not be taken lightly.
FDA Approves Nerlynx for HER2-Positive Breast Cancer Treatment
July 18th 2017Nerlynx (neratinib) was granted approval by the Food and Drug Administration (FDA) for the extended adjuvant treatment of patients with early stage, HER2-positive breast cancer who have already received postoperative Herceptin (trastuzumab).
Abemaciclib Gets a Priority Review to Treat Breast Cancer Subset
July 12th 2017Abemaciclib was granted a priority review to a new drug application (NDA) to treat patients with advanced hormone receptor (HR)­­–positive, HER2-negative breast cancer, according to Eli Lilly and Company, the manufacturer of the CDK4/6 inhibitor.